All Stories

  1. Thalassemias and Sickle Cell Diseases in Pregnancy: SITE Good Practice

    Article • Journal of Clinical Medicine, February 2025, MDPI AG

    Valeria Maria Pinto

  2. Prevalence and mortality trends of hemoglobinopathies in Italy: a nationwide study

    Article • Haematologica, January 2025, Ferrata Storti Foundation (Haematologica)

    Valeria Maria Pinto

  3. Novel therapeutic approaches in thalassemias, sickle cell disease, and other red cell disorders

    Article • Blood, August 2024, American Society of Hematology

    Valeria Maria Pinto

  4. Reduction of extramedullary erythropoiesis and amelioration of anemia in a β‐thalassemia patient treated with thalidomide

    Article • American Journal of Hematology, December 2023, Wiley

    Valeria Maria Pinto

  5. Haemochromatosis in children: A national retrospective cohort promoted by the A.I.E.O.P. (Associazione Italiana Emato‐Oncologia Pediatrica) study group

    Article • British Journal of Haematology, November 2023, Wiley

    Valeria Maria Pinto

  6. Proteome alterations in erythrocytes with PIEZO1 gain-of-function mutations

    Article • Blood Advances, June 2023, American Society of Hematology

    Valeria Maria Pinto

  7. Management of the Sickle Cell Trait: An Opinion by Expert Panel Members

    Article • Journal of Clinical Medicine, May 2023, MDPI AG

    Valeria Maria Pinto

  8. Treating Thalassemia Patients with Luspatercept: An Expert Opinion Based on Current Evidence

    Article • Journal of Clinical Medicine, March 2023, MDPI AG

    Dr paolo ricchi, Valeria Maria Pinto

  9. Coinheritance of PIEZO1 variants and multi‐locus red blood cell defects account for the symptomatic phenotype in beta‐thalassemia carriers

    Article • American Journal of Hematology, March 2023, Wiley

    Roberta Russo, Valeria Maria Pinto

  10. Inflammatory and senescence‐associated mediators affect the persistence of humoral response to COVID‐19 mRNA vaccination in transfusion‐dependent beta‐thalassemic patients

    Article • American Journal of Hematology, March 2023, Wiley

    Valeria Maria Pinto

  11. Reply to “Hepatocellular carcinoma in thalassemia and other hemoglobinopathies”

    Article • Cancer, March 2023, Wiley

    Valeria Maria Pinto

  12. Overall and complication‐free survival in a large cohort of patients with β‐thalassemia major followed over 50 years

    Article • American Journal of Hematology, January 2023, Wiley

    Valeria Maria Pinto

  13. Colchicine Protects Against Cardiomyopathy in Humanized Mouse Model for Sickle Cell Disease

    Article • Blood, November 2022, American Society of Hematology

    Valeria Maria Pinto

  14. The Areal Project: How Virtual Reality Application Could Enhance Patient's Quality Time during Transfusion Therapy in Adult Patients with Thalassemia and Sickle Cell Disease

    Article • Blood, November 2022, American Society of Hematology

    Valeria Maria Pinto

  15. Incidence of cancer and related deaths in hemoglobinopathies: A follow‐up of 4631 patients between 1970 and 2021

    Article • Cancer, November 2022, Wiley

    Valeria Maria Pinto

  16. Effect of Aging on Deferasirox Therapy in Transfusion-dependent Patients. A Prospective- Retrospective, Cohort-study

    Article • Current Drug Metabolism, November 2022, Bentham Science Publishers

    Valeria Maria Pinto, Dr Gian Luca Forni, Francesca Mattioli

  17. Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose

    Article • Blood, October 2022, American Society of Hematology

    Valeria Maria Pinto

  18. Long-Term Neuroradiological and Clinical Evaluation of NBIA Patients Treated with a Deferiprone Based Iron-Chelation Therapy

    Article • Journal of Clinical Medicine, August 2022, MDPI AG

    Valeria Maria Pinto

  19. Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization

    Article • Blood, March 2022, American Society of Hematology

    Valeria Maria Pinto

  20. Thalassaemia is paradoxically associated with a reduced risk of in‐hospital complications and mortality in COVID‐19: Data from an international registry

    Article • Journal of Cellular and Molecular Medicine, March 2022, Wiley

    Valeria Maria Pinto

  21. Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy

    Article • Frontiers in Medicine, March 2022, Frontiers

    Valeria Maria Pinto

  22. Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-thalassemia

    Article • Haematologica, March 2022, Ferrata Storti Foundation (Haematologica)

    Valeria Maria Pinto

  23. Italian patients with hemoglobinopathies exhibit a 5‐fold increase in age‐standardized lethality due to SARS‐CoV‐2 infection

    Article • American Journal of Hematology, December 2021, Wiley

    Valeria Maria Pinto

  24. Hemoglobin A2 and Heterogeneous Diagnostic Relevance Observed in Eight New Variants of the Delta Globin Gene

    Article • Genes, November 2021, MDPI AG

    Valeria Maria Pinto

  25. Hemoglobinopathies and Cancer: Preliminary Results of an Italian Multicenter Experience

    Article • Blood, November 2021, American Society of Hematology

    Valeria Maria Pinto

  26. Complex Modes of Inheritance in Hereditary Red Blood Cell Disorders: A Case Series Study of 155 Patients

    Article • Genes, June 2021, MDPI AG

    Roberta Russo, Valeria Maria Pinto

  27. Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm

    Article • HemaSphere, April 2021, Wiley

    Valeria Maria Pinto

  28. Management of Iron Overload in Beta-Thalassemia Patients: Clinical Practice Update Based on Case Series

    Article • International Journal of Molecular Sciences, November 2020, MDPI AG

    Valeria Maria Pinto

  29. COVID 19 and Hemoglobinopathies: Update of the Italian Experience

    Article • Blood, November 2020, American Society of Hematology

    Valeria Maria Pinto

  30. Manual erythroexchange in sickle cell disease: multicenter validation of a protocol predictive of volume to exchange and hemoglobin values

    Article • Annals of Hematology, July 2020, Springer Science + Business Media

    Valeria Maria Pinto

  31. Development of Algorithm for Clinical Management of Sickle Cell Bone Disease: Evidence for a Role of Vertebral Fractures in Patient Follow-up

    Article • Journal of Clinical Medicine, May 2020, MDPI AG

    Valeria Maria Pinto

  32. SARS‐CoV‐2 infection in beta thalassemia: Preliminary data from the Italian experience

    Article • American Journal of Hematology, May 2020, Wiley

    Valeria Maria Pinto

  33. COVID-19 in a Patient with β-Thalassemia Major and Severe Pulmonary Arterial Hypertension

    Article • Hemoglobin, May 2020, Taylor & Francis

    Valeria Maria Pinto

  34. A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, March 2020, New England Journal of Medicine (NEJM/MMS)

    Dr Ellis J Neufeld, Valeria Maria Pinto

  35. Selecting ß-Thalassemia Patients for Gene Therapy: A Decision-Making Algorithm

    Article • Blood, November 2019, American Society of Hematology

    Valeria Maria Pinto

  36. Management of the aging beta-thalassemia transfusion-dependent population – The Italian experience

    Article • Blood Reviews, November 2019, Elsevier

    Valeria Maria Pinto

  37. Sickle cell disease: a review for the internist

    Article • Internal and Emergency Medicine, August 2019, Springer Science + Business Media

    Valeria Maria Pinto

  38. Current challenges in the management of patients with sickle cell disease – A report of the Italian experience

    Article • Orphanet Journal of Rare Diseases, May 2019, Springer Science + Business Media

    Valeria Maria Pinto

  39. Access to emergency departments for acute events and identification of sickle cell disease in refugees

    Article • Blood, May 2019, American Society of Hematology

    Valeria Maria Pinto

  40. Efficacy and safety of deferiprone for the treatment of superficial siderosis: results from a long-term observational study

    Article • Neurological Sciences, March 2019, Springer Science + Business Media

    Valeria Maria Pinto

  41. Daily alternating deferasirox and deferiprone therapy successfully controls iron accumulation in untreatable transfusion-dependent thalassemia patients

    Article • American Journal of Hematology, August 2018, Wiley

    Valeria Maria Pinto, Dr Gian Luca Forni

  42. Risk factors for heart disease in transfusion-dependent thalassemia: serum ferritin revisited

    Article • Internal and Emergency Medicine, June 2018, Springer Science + Business Media

    Valeria Maria Pinto

  43. Multi-gene panel testing improves diagnosis and management of patients with hereditary anemias

    Article • American Journal of Hematology, February 2018, Wiley

    Dr Gian Luca Forni, Roberta Russo, Valeria Maria Pinto

  44. Lack of correlation between heart, liver and pancreas MRI‐R2*: Results from long‐term follow‐up in a cohort of adult β‐thalassemia major patients

    Article • American Journal of Hematology, January 2018, Wiley

    Valeria Maria Pinto

  45. Noninvasive monitoring of liver fibrosis in sickle cell disease: Longitudinal observation of a cohort of adult patients

    Article • American Journal of Hematology, October 2017, Wiley

    Dr Gian Luca Forni, Valeria Maria Pinto

  46. Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies

    Article • American Journal of Hematology, October 2017, Wiley

    Dr Gian Luca Forni, Valeria Maria Pinto

  47. Safety and Efficacy of Direct-Acting Antiviral Drugs in Patients with Haemoglobinophaties and Chronic Hepatitis C Infection

    Article • Blood, December 2016, American Society of Hematology

    Valeria Maria Pinto

  48. Comparison between different software programs and post-processing techniques for the MRI quantification of liver iron concentration in thalassemia patients

    Article • La radiologia medica, June 2016, Springer Science + Business Media

    Valeria Maria Pinto

  49. Management of beta-thalassemia-associated osteoporosis

    Article • Annals of the New York Academy of Sciences, March 2016, Wiley

    Dr Andrea Giusti, Valeria Maria Pinto

  50. SF3B1 Mutation Is an Independent Predictor of Parenchymal Iron Overload in Myelodysplastic Syndromes

    Article • Blood, December 2015, American Society of Hematology

    Valeria Maria Pinto

  51. Iron overload‐related heart failure in a patient with transfusion‐dependent myelodysplastic syndrome reversed by intensive combined chelation therapy

    Article • Clinical Case Reports, October 2015, Wiley

    Valeria Maria Pinto

  52. Characterization of ferromagnetic or conductive properties of metallic foreign objects embedded within the human body with magnetic iron detector (MID): Screening patients for MRI

    Article • Magnetic Resonance in Medicine, March 2015, Wiley

    Valeria Maria Pinto

  53. Determination of deferasirox plasma concentrations: do gender, physical and genetic differences affect chelation efficacy?

    Article • European Journal Of Haematology, September 2014, Wiley

    Francesca Mattioli, Valeria Maria Pinto

  54. End-stage anorexia nervosa in a young man: multifaceted metabolic, endocrine and infectious derangements managed in an internal medicine setting

    Article • Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity, May 2014, Springer Science + Business Media

    Valeria Maria Pinto

  55. Prevalence and Risk Factors for Pulmonary Arterial Hypertension in a Large Group of β-Thalassemia Patients Using Right Heart Catheterization

    Article • Circulation, January 2014, Wolters Kluwer Health

    Valeria Maria Pinto

  56. Transferrin‐immune complex disease: A potentially overlooked gammopathy mediated by IgM and IgG

    Article • American Journal of Hematology, October 2013, Wiley

    Dr Gian Luca Forni, Valeria Maria Pinto

  57. Neridronate improves bone mineral density and reduces back pain in β‐thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel‐arm, open‐label study

    Article • British Journal of Haematology, May 2012, Wiley

    Dr Gian Luca Forni, Valeria Maria Pinto

  58. Chemosensitivity of nonleukemic clonogenic precursors in AML patients in complete remission: Association with CD34+ mobilization and with disease-free survival

    Article • Experimental Hematology, January 2012, Elsevier

    Valeria Maria Pinto

  59. Manual erythroexchange for chronic transfusion therapy in patients with sickle cell syndromes unresponsive to hydroxyurea: A long‐term follow‐up

    Article • American Journal of Hematology, November 2010, Wiley

    Dr Gian Luca Forni, Valeria Maria Pinto

  60. Contact with the bone marrow microenvironment readdresses the fate of transplanted hematopoietic stem cells

    Article • Experimental Hematology, October 2010, Elsevier

    Valeria Maria Pinto

  61. Beta‐2‐microglobulin is an independent predictor of progression in asymptomatic multiple myeloma

    Article • Cancer, April 2010, Wiley

    Valeria Maria Pinto

  62. Safe and effective use of plerixafor plus G‐CSF in dialysis‐dependent renal failure

    Article • American Journal of Hematology, April 2010, Wiley

    Valeria Maria Pinto

  63. Daily alternating deferasirox and deferiprone therapy for “hard‐to‐chelate” β‐thalassemia major patients

    Article • American Journal of Hematology, April 2010, Wiley

    Dr Gian Luca Forni, Valeria Maria Pinto

  64. Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants

    Article • British Journal of Pharmacology, July 2009, Springer Science + Business Media

    Valeria Maria Pinto

  65. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors

    Article • British Journal of Haematology, July 2009, Wiley

    Dr Francesco Bertoni, Dr ALESSANDRO Gozzetti, Valeria Maria Pinto

  66. Direct Intra-Bone Injection of Unrelated Cord Blood Cells Overcomes the Problem of Delayed Engraftment and Improves the Feasibility of Hematopoietic Transplant in Adult Patients.

    Article • Blood, November 2007, American Society of Hematology

    Valeria Maria Pinto

  67. Failure of CD34+ Mobilization in AML Patients Is Associated to an Abnormally High Chemosensitivity of Non Leukemic CFU-GM.

    Article • Blood, November 2007, American Society of Hematology

    Valeria Maria Pinto

  68. Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age

    Article • Cytotherapy, January 2007, Elsevier

    Valeria Maria Pinto

  69. Intermediate dose etoposide plus G-CSF 16 g/kg is more effective than cyclophosphamide 4 g/m2plus G-CSF 10 g/kg in PBSC mobilization of lymphoma patients

    Article • Leukemia & Lymphoma, January 2007, Taylor & Francis

    Valeria Maria Pinto

  70. Adverse Events after Infusions of Cryopreserved Hematopoietic Stem Cells Depend on Non-Mononuclear Cell in Infused Suspension and on Patient Age.

    Article • Blood, November 2006, American Society of Hematology

    Valeria Maria Pinto